2025 second_quarter Filing
Q2Expenses
$130K
Method: A
Filed
August 20, 2025
Lobbying Activities
PharmacyView all
Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Health IssuesView all
Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Medical/Disease Research/Clinical Labs
Lobbyists (1)
LAURA EFROS